← Database
Growth-Hormone Releasing Peptide

GHRP-2

Third-party suppliers · research use only · not an endorsement. Some links are affiliate links — purchases made through them may earn this site a commission.
Overview

Used as a GH-stimulation diagnostic in some regions; studied as a secretagogue; not an FDA-approved therapy.

How it works

GHRP-2 (pralmorelin) is a potent growth-hormone-releasing peptide that, like the others in its family, activates the ghrelin receptor to drive GH release.

It produces strong, reliable GH pulses with relatively modest appetite, cortisol, and prolactin effects. That reliability is why, in some countries (notably Japan), it's actually used as an approved diagnostic agent to test how well a patient's pituitary can secrete growth hormone.

Outside that diagnostic role it is not an FDA-approved therapy; as a treatment it remains a research compound.

Mechanism · Detailed Analysis
Molecular targetA potent GHS-R1a agonist (pralmorelin).
Signaling & downstream effectsProduces robust GH pulses with modest appetite, cortisol, and prolactin effects.
PharmacokineticsApproved as a GH-stimulation diagnostic agent in Japan.
CaveatsNot an FDA-approved therapy.
Published EvidenceLoading cited studies from PubMed…
Human Data ···

Searching the published record…

Animal ···

Searching the published record…

In Vitro ···

Searching the published record…

Educational aggregation of public literature. Not medical advice and not a recommendation to use any compound. Many compounds here are not approved for human use. Consult a licensed clinician.